February 13, 2026

Geron Corporation (GERN) Stock Analysis: A Potential 108% Upside Opportunity in Biotechnology

For individual investors hunting for promising opportunities in the healthcare sector, Geron Corporation (NASDAQ: GERN) presents a compelling case with a potential upside of 108.59%. This biopharmaceutical company, headquartered in..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 18.52% Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a key player in the healthcare sector, has drawn considerable attention with its strategic focus on pain management medicines. As a specialty pharmaceutical company based..

Arcus Biosciences, Inc. (RCUS)

⚠️ No article content returned.

..

Intellia Therapeutics (NTLA) Investor Outlook: Exploring a 105% Potential Upside in Gene Editing Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneer in the burgeoning field of gene editing, is capturing investor attention with a staggering potential upside of 105.31%. The biotechnology company, headquartered in..

Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount

For the six months to 30 November 2025, NAV per share rose to 113.21p and revenue earnings increased year-on-year, supporting a higher interim dividend...

Business relief reform and succession risk

Business Relief reform from 2026 introduces new caps that could materially affect succession plans for growing UK companies...

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026...

Design priorities reshape kitchen investment landscape in 2026

2026 kitchen design trends show clear demand for practical features, natural materials and timeless styling in wet zones...

GCP Infra reports £853.8m portfolio and advances capital allocation plan

As at 31 December 2025, GCP Infra reported a NAV of 100.27p per share and a portfolio yield of 8.0% across 47 investments...

RTW Biotech Opportunities reports January NAV of US$2.37; sector activity builds

As at 31 January 2026, RTW Biotech Opportunities Ltd recorded an unaudited NAV of US$2.37 per share, reflecting a 3.6% monthly decline...

TwentyFour Income Fund reports 9.65% one-year NAV return to January 2026

TwentyFour Income Fund Limited has published its January 2026 factsheet, reporting a 9.65% one-year NAV total return and a current mark-to-market yield of 9.93% as at 30 January 2026...

Vp plc Earnings Reset Reflects Market Headwinds, Says Equity Development

Vp plc resets earnings expectations amid market headwinds, with Equity Development highlighting recovery potential and attractive sub 10x valuation...

NatWest Group posts higher profit and dividend growth in 2025

NatWest Group reported attributable profit of £5.5 billion for 2025, with earnings per share up 27% and dividends per share rising 51% year-on-year...

Drax appoints Mark Clare as Non-Executive Director

Drax Group plc has appointed Mark Clare as a non-executive director, effective 13 February 2026. Clare brings extensive board and executive experience across the energy, consumer service and construction sectors,..

Tern Plc launches £384,408 Open Offer at 0.40p per share

Tern Plc has announced an Open Offer to raise up to £384,408 through the issue of up to 96,101,957 shares at 0.40p each, a 20% discount to the 12 February..

Wizz Air Holdings (WIZZ.L): Investor Outlook Amidst Volatile Price Targets and Robust Growth

Wizz Air Holdings Plc (WIZZ.L), a key player in the European low-cost airline sector, is drawing investor attention with its significant market presence and intriguing financial metrics. With a market..

Volution Group PLC (FAN.L) Stock Analysis: Exploring a 9% Potential Upside in the Building Products Sector

Volution Group PLC (FAN.L), a prominent player in the building products and equipment industry, is capturing investor attention with its positioning within the industrial sector. Headquartered in Crawley, UK, the..

Zigup Plc (ZIG.L) Stock Analysis: A 28.81% Potential Upside Beckons Investors

For investors eyeing opportunities in the industrial rental and leasing sector, Zigup Plc (ZIG.L) presents an intriguing proposition. With its current stock price at 390.5 GBp and a bullish analyst..

Worldwide Healthcare Trust PLC (WWH.L): Analyzing the Path Forward with a Singular Buy Rating

Worldwide Healthcare Trust PLC (WWH.L) stands as a compelling investment opportunity, particularly for those with a keen interest in the healthcare sector. With a market capitalization of $1.35 billion, this..

TBC Bank Group PLC (TBCG.L) Investor Outlook: Potential 21.81% Upside and Robust Dividend Yield

TBC Bank Group PLC (TBCG.L), a significant player in the regional banking sector, presents a compelling opportunity for investors seeking both growth and income. With a market capitalization of $2.35..

Search

Funds

February 13, 2026

Diverse Income Trust Plc reports 8.5% H1 returns and review of redemptions and discount

For the six months to 30 November 2025, NAV per share rose to 113.21p and revenue earnings increased year-on-year, supporting a higher interim dividend...

Business relief reform and succession risk

Business Relief reform from 2026 introduces new caps that could materially affect succession plans for growing UK companies...

Changing clinician behaviour reshapes commercial strategy for 2026

As clinician engagement becomes more digital and measurable, companies that act on behavioural data can improve targeting, reduce risk and strengthen competitive positioning in 2026...

Design priorities reshape kitchen investment landscape in 2026

2026 kitchen design trends show clear demand for practical features, natural materials and timeless styling in wet zones...

GCP Infra reports £853.8m portfolio and advances capital allocation plan

As at 31 December 2025, GCP Infra reported a NAV of 100.27p per share and a portfolio yield of 8.0% across 47 investments...

RTW Biotech Opportunities reports January NAV of US$2.37; sector activity builds

As at 31 January 2026, RTW Biotech Opportunities Ltd recorded an unaudited NAV of US$2.37 per share, reflecting a 3.6% monthly decline...

TwentyFour Income Fund reports 9.65% one-year NAV return to January 2026

TwentyFour Income Fund Limited has published its January 2026 factsheet, reporting a 9.65% one-year NAV total return and a current mark-to-market yield of 9.93% as at 30 January 2026...

Vp plc Earnings Reset Reflects Market Headwinds, Says Equity Development

Vp plc resets earnings expectations amid market headwinds, with Equity Development highlighting recovery potential and attractive sub 10x valuation...

NatWest Group posts higher profit and dividend growth in 2025

NatWest Group reported attributable profit of £5.5 billion for 2025, with earnings per share up 27% and dividends per share rising 51% year-on-year...

Drax appoints Mark Clare as Non-Executive Director

Drax Group plc has appointed Mark Clare as a non-executive director, effective 13 February 2026. Clare brings extensive board and executive experience across the energy, consumer service and construction sectors, including senior roles at Centrica plc, United Utilities Group plc and Barratt Developments plc...

Tern Plc launches £384,408 Open Offer at 0.40p per share

Tern Plc has announced an Open Offer to raise up to £384,408 through the issue of up to 96,101,957 shares at 0.40p each, a 20% discount to the 12 February 2026 closing price...
Search

Funds

February 13, 2026

FTSE 100

Funds